Reply  by Iwakura, Katsuomi
Hyperglycemia and No-Reflow
Phenomenon in Acute Myocardial Infarction
Dr. Iwakura and colleagues in a recent issue of the Journal (1)
conclude that, from a retrospective analysis of 146 patients,
hyperglycemia might be associated with impaired microvascular
function after acute myocardial infarction. The investigators de-
scribe an independent relation between elevated blood glucose
levels on admission and no-reflow phenomenon after primary
angioplasty of the infarct-related artery. They also state that this
relation was independent of HbA1c level or diabetes mellitus
(DM), because no differences existed in HbA1c levels or in the in-
cidence of DM in both the no-reflow group and the reflow group.
We have some considerations about these results. First, the
investigators defined hyperglycemia by the optimal cutoff to
differentiate the patients showing no reflow with a receiver-
operating characteristic curve analysis. By using this cutoff in the
same cohort they found a relation between hyperglycemic patients
and no-reflow phenomenon. The researchers have generated an
interesting hypothesis, but new studies in another patient popula-
tion still have to prove the validity of this cutoff. Furthermore, we
are interested in details with regard to the methods used to
determine blood glucose and HbA1c levels. No information was
reported as to whether the blood glucose level was measured with
point-of-care of laboratry measurements or whether their method
has been validated in critically ill patients. Clinically relevant
differences in blood glucose levels have been observed in patients
with shock (2), and there may be an influence of acidosis and
hematocrit values (3). Finally, the absolute differences of 0.3% in
HbA1c and 13% in incidence of DM were not statistically related
to the no-reflow phenomenon, but this may be due to the small
number of patients. The investigators found that 45.3% of the
patients with hyperglycemia were diabetic versus 9.9% in patients
without hyperglycemia (p  0.0001).
The hypothesis that acute hyperglycemia (i.e., hyperglycemia at
admission) is associated with the no-reflow phenomenon is intrigu-
ing. We, however, hypothesize that this relation is not independent of
chronic hyperglycemia (i.e., elevated HbA1c level and/or DM).
Therefore, new clinical studies have to determine the effect of
hyperglycemia on no-reflow and the impact of metabolic regulation.
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REPLY
We thank Dr. Zijlstra and colleagues for their interest in our work
and for their comments. We agree with them that further study is
preferable to prove the validity of the present cutoff point of blood
glucose for prediction of the no-reflow phenomenon. We mea-
sured blood glucose in whole arterial blood samples with reflec-
tance glucometer at the bedside. The measurements of glucose in
whole blood are predictably 10% to 15% less than those in plasma,
and arterial blood glucose is higher than venous glucose. Although
capillary blood glucose measurement could be inaccurate in pa-
tients with severe hypotension, whole-blood glucose measurement
has been reported to be accurate even in critically ill patients (1)
(also see Ref. 1 in Dr. van der Horst’s letter). Moreover, only 7
(4.8%) of 146 patients had blood pressure 100 mm Hg. Hemat-
ocrit might also affect blood glucose measurement, especially in the
whole-blood sample. However, the effects of hematocrit could be
important only at high hematocrit levels, such as55% (2), and no
patients in our study had such a high hematocrit. Thus, we believe
that the effects of blood pressure or hematocrit on blood glucose
measurement could be negligible in our study.
It is important to question whether chronic hyperglycemia also
affects the development of the no-reflow phenomenon. In our
previous report based on the 199 patients with anterior acute
myocardial infarction, none of whom were enrolled in our recent
study, we did not find that diabetes mellitus predicts the no-reflow
phenomenon independently (3), as in our recent study. We also
performed multivariate logistic analysis again and found that blood
glucose level could be an independent predictor of the no-reflow
phenomenon (p  0.008, odds ratio [95% confidence interval] 
1.03 [1.01 to 1.06]) even among the 105 patients without diabetes.
Thus, we concluded that acute hyperglycemia in itself is related
with the no-reflow phenomenon independently from chronic
hyperglycemia. Akbari et al. (4) also reported that acute hypergly-
cemia impairs vasodilation in microcirculation even in healthy
subjects.
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